b-Secretase Inhibitors
23
REFERENCES
1. Citron, M. Secretases as targets for the treatment of Alzheimer’s disease. Mol.
Med. Today 2000, 6, 392–397.
2. Evin, G.; Weidemann, A. Biogenesis and metabolism of Alzheimer’s disease Ab
amyloid peptides. Peptides 2000, 23, 1285–1297.
3. (a) Ghosh, A. K.; Bilcer, G.; Harwood, C.; Reiko, K.; Shin, D.; Hussain, K. A.;
Hong, L.; Loy, J. A.; Nguyen, C.; Koelsch, G.; Ermolieff, J.; Tang, J. Structure-
based design: Potent inhibitors of human brain memapsin 2 (b-secretase).
J. Med. Chem. 2001, 44, 2865–1297; (b) Ghosh, A. K.; Lin, H.; Tang, J.
b-Secretase as a therapeutic target for inhibitor drugs. Curr. Med. Chem. 2002,
9, 1135–1144.
4. Hirokazu, T.; Terukazu, K.; Akira, O.; Nobutaka, F. Synthesis of potent
b-secretase inhibitors containing a hydroxyethylamine dipeptide isostere and
their structure–activity relationship studies. Org. Biomol. Chem. 2003, 1,
2468–2473.
5. (a) Tung, J. S.; Davis, D. L.; Anderson, J. P.; Walker, D. E.; Shumeye, M.;
Jewett, N.; Hom, R. K.; Sukanto, S.; Thorsett, E. D.; John, V. Design of
substrate-based inhibitors of human b-secretase. J. Med. Chem. 2002, 45,
259–262; (b) Hom, R. K.; Fang, L. Y.; Shumeye, M.; Tung, J. S.; Guinn, A. C.;
Walker, D. E.; Davis, D. L.; Failunas, A. F.; Thorsett, E. D.; Sukanto, S.;
Knops, J. E.; Jewett, N. E.; Anderson, J. P.; John, V. Design and synthesis of
statine-based cell-permeable peptidomimetic inhibitors of human b-secretase.
J. Med. Chem. 2003, 46, 1799–1802; (c) Hu, J. D.; Cwi, C. L.; Smiley, D. L.;
Timm, D.; Erickson, J. A.; McGee, J. E.; Yang, H. C.; Mendel, D.; May, P. C.;
Shapiro, M.; McCarthy, J. R. Design and synthesis of statine-containing BACE
inhibitors. Bioorg. Med. Chem. Lett. 2003, 13, 4335–4339.
6. A brief list of methods used in the synthesis of HED: (a) Jones, D. M.; Nilsson, B.;
Szelke, M. A short stereocontrolled synthesis of hydroxyethylene dipeptide
isosteres. J. Org. Chem. 1993, 58, 2286–2290; (b) Andrew, H. F.;
Robert, L. K.; Edward, F. K. A short stereoselective synthesis of the lactone
precursor to 2R,4S,5S hydroxyethylene dipeptide isosteres. J. Org. Chem. 1986,
`
´
51, 4828–4833; (c) Peyrat, J.-F.; Chaboche, C.; Figadere, B.; Cave, A. A formal
stereoselective synthesis of a hydroxyethylene dipeptide isosteres. Tetrahedron
Lett. 1995, 36, 2757–2760; (d) Chakraborty, T. K.; Hussain, K. A.;
Thippeswamy, D. A simple strategy for the synthesis of hydroxyethylene
dipeptide isostere from D-glucose. Tetrahedron 1995, 51, 3873–3880;
(e) Mitrochkine, A. A.; Blain, I.; Bit, C.; Canlet, C.; Pierre, S.; Courtieu, J.;
´
Reglier, M. Enantioselective synthesis of cis- and trans-2(S)-amino-1-d-indane:
debrominative [1,2]-hydride shift rearrangement by reduction of cis-2-azido-1-
bromoindane with LiAID4. J. Org. Chem. 1997, 62, 6240–6244;
(f) Kempf, D. J. Dipeptide analogs. Versatile synthesis of the hydroxyethylene
isostere. J. Org. Chem. 1986, 51, 3921–3926; (g) Ghosh, A. K.; McKee, S. P.;
Thompson, W. J. An efficient synthesis of hydroxyethylene dipeptide isosteres:
the core unit of potent HIV-1 protease inhibitors. J. Org. Chem. 1991, 56,
6500–6503; (h) Benedetti, F.; Maman, P.; Norbedo, S. New synthesis of 5-
amino-4-hydroxy-2,6-dimethylheptanoic acid, a hydroxyethylene isostere of
the Val-Ala dipeptide. Tetrahedron Lett. 2000, 41, 10075–10078;
(i) Dragovich, P. S.; Prins, T. J.; Zhou, R.; Fuhrman, S. A.; Patick, A. K.;
Matthews, D. A.; Ford, C. E.; Meador, J. W.; Ferre, R. A.; Worland, S. T.
Structure-based design, synthesis, and biological evaluation of irreversible